Axsome Therapeutics, Inc. (AXSM)
233.64
+3.02
(+1.31%)
USD |
NASDAQ |
May 21, 16:00
234.55
+0.91
(+0.39%)
After-Hours: 19:59
Axsome Therapeutics Research and Development Expense (TTM) : 190.82M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 21.57B |
| Indivior Pharmaceuticals, Inc. | 67.00M |
| Eli Lilly & Co. | 14.11B |
| Esperion Therapeutics, Inc. | 44.28M |
| Ocular Therapeutix, Inc. | 220.45M |